Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Assess Pyloric Or Pseudopyloric Metaplasia Of Corpus By Tff2 Immunohistochemistry Stains

Research Leaders

10 sponsors active, led by Hospital Ángeles, Clínica Londres, Mexico City

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Phase 3 (1)
Phase 4 (1)

Trial Status

Not Yet Recruiting1
Recruiting1
Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Assess Pyloric Or Pseudopyloric Metaplasia Of Corpus By Tff2 Immunohistochemistry Stains1
  • Pla Pantolevofloxazithro1
  • The Assessment Of Corpuspredominant Gastritis Index Cgi Operative Link For Gastritis Assessment Olga And Operative Link On Gastric Intestinal Metaplasia Assessment Olgim1
  • Assess Pyloric Or Pseudopyloric Metaplasia Of Corpus By He Stains1
  • Modified Bismuthcontaining Eradication Treatment1

Active Sponsors

  • Hospital Ángeles, Clínica Londres, Mexico City1
  • National Cheng-Kung University Hospital1
  • Technical University of Munich1
  • Tainan Hospital, Ministry of Health and Welfare1
  • Torre Mayo, Metepec, State of Mexico1

Top Investigators

Related Conditions

  • Microbial Colonization1
  • Helicobacter Pylori Infection1
  • Metaplasia1
  • Helicobacter Eradication1
  • Anemia Pernicious1

Activity Timeline